Additional adverse events, including fatigue, dizziness, alopecia, and gallbladder-related disorders, were more frequent with CagriSema
the invention also relates to novel uses and methods of treatments using the aforementioned salts and/or compositions, in particular, with respect to the treatment of disturbances connected with either nitric oxide (NO) formation or impaired NO-system functions, in particular, hypertension, angina, impotence, circulatory and septic shock, stroke, inflammation, respiratory distress syndrome, adhesion and aggregation of platelets and leukocytes, endothelial dysfunction, gastrointestinal lesions, peristalsis disturbances, diabetes, pancreatitis, hypotension and Parkinson's disease
Reconstituted stability: 30 days at 2-8C in low-protein-binding polypropylene containers, protected from light
Recommended storage conditions for lyophilized BPC-157: Temperature: 2-8C (refrigerator) for standard storage, or -20C (freezer) for long-term storage Light: Protect from direct light keep in original packaging or opaque container Humidity: Keep sealed until reconstitution
Extended-release forms allow once-daily intake
Contact us today to book your appointment!